Yoshida, Kiryu http://orcid.org/0000-0002-2293-0132
Mizukami, Takuya
Fukagawa, Masafumi
Akizawa, Tadao
Morohoshi, Hokuto
Sambe, Takehiko
Ito, Hidetoshi
Ogata, Hiroaki
Uchida, Naoki
,
Article History
Received: 1 August 2022
Accepted: 10 October 2022
First Online: 27 October 2022
Declarations
:
: TM reported receiving consultancy fees from Zeon Medical Inc.; research grants from Boston Scientific; and speaker fees from Abbott Vascular, Cathworks, and Boston Scientific. MF reported receiving lecture fees from Bayer Yakuhin, Kyowa Kirin, Kissei, Ono Pharmaceutical and Sanwa Kagaku; and grants from Kyowa Kirin, Chugai, and Torii. TA reported receiving consulting and lecture fees from Bayer Yakuhin, Astellas, Kyowa Kirin, Kissei Pharmaceutical, Ono Pharmaceutical, Fuso Pharmaceutical Industry, and Torii Pharmaceutical; consulting fees from GlaxoSmithKline, JT Pharmaceutical, Nipro Corporation, Otsuka, and Sanwa Kagaku; and lecture fees from Chugai Pharmaceutical and Mitsubishi Tanabe Pharma. HO reported receiving lecture fees from Bayer Yakuhin, Kyowa Kirin, Torii Pharmaceutical, Otsuka, Kissei Pharmaceutical, Mitsubishi Tanabe Pharma, Sumitomo Dainippon Pharm, Daiichi Sankyo, Kowa, and Ono Pharmaceutical; grants from Torii Pharmaceutical and Ono Pharmaceutical; and consulting fees from YL Biologics. NU reported receiving consultancy fees from TOA EIYO, Meiji Seika Pharma, AstraZeneca, Daiichi Sankyo Company Ltd, Eisai Co., Ltd, Sanwa Kagaku Kenkyusho Co., Ltd, Kyorin Pharmaceutical Co., Ltd., Sanofi K.K., NapaJen Pharma, GC Showayakuhin Corporation, Ito Life Science, Takata Pharmaceutical Co., Ltd., and SSP Co., Ltd.; and lecture fees from TOA EIYO, Meiji Seika Pharma, AstraZeneca, Daiichi Sankyo Company Ltd, and NapaJen Pharma. No other disclosures were reported.
: All procedures performed in the LANDMARK study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This post-hoc analysis was approved by the ethics committee of Showa University (approval number 21-059-B).
: Informed consent was obtained from all individual participants included in the LANDMARK study.